Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Ann Vasc Surg. 2020 Apr 9;68:369–383. doi: 10.1016/j.avsg.2020.03.040

Table 1.

Demographic and health characteristics of participants (n = 44) by type 2 diabetes (T2DM) status.

Mean (SD) or n [%]

Characteristic Overall (n = 44) PAD+T2DM (n = 19) PAD (n = 25) p+
Age (years) 72.3 (7.1) 72.1 (8.8) 72.5 (5.7) .846
Sex (female) 21 [47.7] 7 [36.8] 14 [56.0] .208
Non-Hispanic white 40 [90.9] 17 [89.5] 23 [92.0] .585
BMI (kg/m2) 28.6 (5.8) 30.5 (6.3) 27.1 (5.0) .050
Marital Status .471^
 Single 3 [7.0] 2 [10.5] 1 [4.2]
 Married/living with partner 28 [65.1] 10 [52.6] 18 [75.0]
 Divorced 3 [7.0] 2 [10.5] 1 [4.2]
 Widowed 9 [20.9] 5 [26.3] 4 [16.7]
Education .643^
 High school diploma or less 10 [22.7] 3 [15.8] 7 [28.0]
 Some college 23 [52.3] 11 [57.9] 12 [48.0]
 4-year college degree 5 [11.4] 3 [15.8] 2 [8.0]
 Graduate school 6 [13.6] 2 [10.5] 4 [16.0]
Employment status .912^
 Full-time 6 [13.6] 3 [15.8] 3 [12.0]
 Part-time 2 [4.5] 1 [5.3] 1 [4.0]
 Retired 36 [81.8] 15 [78.9] 21 [84.0]
ABI (lower leg) 0.71 (0.25) 0.68 (0.27) 0.73 (0.24) .534
Lower extremity revascularization (any) 18 [40.9] 8 [42.1] 10 [40.0] .888
 Percutaneous 17 [38.6] 7 [36.8] 10 [40.0] .831
 Bypass 7 [15.9] 3 [15.8] 4 [16.0] .657
Amputation 1 [2.3] 1 [5.3] 0 [0] .432
Smoking status
 Never 8 [18.2] 4 [21.1] 4 [16.0] 1.000
 Current 4 [9.1] 1 [5.3] 3 [12.0] .415
 Former 32 [72.7] 14 [73.7] 18 [72.0] .622
 Pack years 45.3 (28.7) 46.5 (34.0) 44.5 (25.2) .850
Comorbid Conditions
 Hypertension 41 [93.2] 18 [94.7] 23 [92.0] .604
 Hypercholesterolemia 42 [95.5] 17 [89.5] 25 [100] .181
 Coronary artery disease/MI 24 [54.5] 11 [57.9] 13 [52.0] .697
 Carotid endarterectomy 6 [13.6] 2 [10.5] 4 [16.0] .684
 Stroke/TIA 5 [11.4] 3 [15.8] 2 [8.0] .638
 COPD/Emphysema 12 [27.3] 7 [36.8] 5 [20.0] .214
 Osteoarthritis 28 [63.6] 12 [63.2] 16 [64.0] .954
Comorbidity index (out of 8) 3.6 (1.4) 4.4 (1.2) 3.0 (1.2) .001
Medication use
 Number of medications 13.0 (5.4) 14.0 (5.2) 12.3 (5.6) .331
 Current use of cilostazol/pentoxifylline 9 [20.5] 3 [15.8] 6 [24.0] .710
 Current use of metformin 11 [25.0] 11 [57.9] 0 [0] N/A

Note.

+

t-test or Pearson chi-square as appropriate for continuous or categorical data, respectively.

Fisher’s Exact Test (expected cell counts less than 5).

^

Likelihood ratio.

ABI, ankle-brachial index; BMI, body mass index; COPD, chronic obstructive pulmonary disease; MI, myocardial infarction; PAD, peripheral artery disease; PAD+T2DM, peripheral artery disease and comorbid type 2 diabetes mellitus; T2DM, type 2 diabetes mellitus; TIA, transient ischemic attack